- Home
- VTS vs AQST Comparison
VTS vs AQST Comparison
Compare VTS & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTS
- AQST
- Stock Information
- Founded
- VTS 2014
- AQST 2004
- Country
- VTS United States
- AQST United States
- Employees
- VTS N/A
- AQST N/A
- Industry
- VTS Oil & Gas Production
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- VTS Energy
- AQST Health Care
- Exchange
- VTS Nasdaq
- AQST Nasdaq
- Market Cap
- VTS 895.8M
- AQST 809.3M
- IPO Year
- VTS N/A
- AQST 2018
- Fundamental
- Price
- VTS $22.00
- AQST $6.88
- Analyst Decision
- VTS Strong Buy
- AQST Strong Buy
- Analyst Count
- VTS 4
- AQST 7
- Target Price
- VTS $28.25
- AQST $10.71
- AVG Volume (30 Days)
- VTS 304.3K
- AQST 3.2M
- Earning Date
- VTS 11-03-2025
- AQST 10-31-2025
- Dividend Yield
- VTS 10.26%
- AQST N/A
- EPS Growth
- VTS 27.28
- AQST N/A
- EPS
- VTS 1.12
- AQST N/A
- Revenue
- VTS $239,904,000.00
- AQST $44,132,000.00
- Revenue This Year
- VTS $28.41
- AQST N/A
- Revenue Next Year
- VTS N/A
- AQST $51.39
- P/E Ratio
- VTS $19.65
- AQST N/A
- Revenue Growth
- VTS 4.55
- AQST N/A
- 52 Week Low
- VTS $18.90
- AQST $2.12
- 52 Week High
- VTS $28.41
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- VTS 37.72
- AQST 60.59
- Support Level
- VTS $21.34
- AQST $6.63
- Resistance Level
- VTS $22.19
- AQST $7.55
- Average True Range (ATR)
- VTS 0.53
- AQST 0.41
- MACD
- VTS -0.02
- AQST -0.04
- Stochastic Oscillator
- VTS 28.34
- AQST 62.04
About VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.